The Head, Oncology Clinical Development- ADCs, will report to the SVP, Head of Oncology Clinical Development. The role holder will be accountable for the design and implementation of the clinical development strategy across a particular asset across multiple tumor types spanning early- and late-phase development. This includes the strategic clinical positioning of the asset, combinations, and associated clinical development plans.

This role requires an experienced, cross-matrix senior leader capable of implementing and executing an integrated clinical strategy in support of the successful clinical development, translational research, regulatory filing and initial market launch of a growing portfolio of innovative and transformational Oncology agents.

Key Responsibilities & Accountabilities:

Clinical Development Strategy & Portfolio Leadership

• Accountable for end0end clinical development of an MOA-focused, multi-tumor asset, including registrational trials, regulatory approval, and initial market launch, ensuring scientific rigor, speed, and quality of execution.
• Shape and drive the scientific and clinical development strategy for the asset and disease areas, aligned with Oncology Tumor Team strategy and broader Oncology portfolio priorities.
• Evaluate, champion, and enable the use of novel approaches (e.g., AI/ML, innovative trial designs, external and real0world data sources) where they add clear scientific, operational, or decision0making value to clinical development.

Program Oversight, Governance & Visibility

• Provide oversight and connectedness across the asset program, maintaining visibility to progress, risks, dependencies, and trade0offs across the Oncology portfolio.
• Serve as the default senior clinical representative at key governance forums (e.g., DRB, PIB, program and portfolio governance) for the asset, ensuring strong clinical leadership, continuity, and high0quality decision0making.
• Represent the Oncology Clinical Development organization internally and externally, including presenting at high0impact forums such as congress all0hands, senior leadership reviews, and advisory boards.
• Lead scientific advisory boards and other external engagements to inform asset strategy, competitive positioning, and portfolio decisions, incorporating emerging science and external expert insight.

Cross0Functional Leadership & Connector Role

• Act as a senior connector across functions, partnering closely with Oncology Research, Precision Medicine/Companion Diagnostics, Medical Affairs, Commercial, Competitive Intelligence, and Global Product Strategy to drive integrated development and lifecycle planning.
• Drive asset alignment across research, development, and commercialization planning, and ensuring cohesive execution against shared objectives.
• Build and sustain strong internal and external partnerships to accelerate decision0making, resolve complexity, and optimize development outcomes in a matrixed environment.

Culture & Capability Building

• Foster a culture of empowerment, scientific excellence, inclusion, and collaboration, aligned with OneOncology values, while modeling strong, visible leadership.
• Actively remove organizational barriers and enable teams to operate effectively and autonomously within a complex, global matrix environment.

Standards, Processes & Continuous Improvement

• Contribute to the establishment and continuous evolution of clinical development standards, processes, and best practices across Oncology, ensuring consistency, quality, and regulatory readiness.
• Ensure timely access to relevant external scientific and competitive intelligence (e.g., congress data, emerging science, competitor activity) to inform clinical development decisions and portfolio strategy.

Skills & Capabilities

• Senior clinical and scientific leadership in early0 and late0phase oncology drug development, including FTIH through registrational trials and launch readiness.
• Strong ability to translate science and translational insight into differentiated clinical development strategies across disease areas and portfolios.
• Proven capability to operate at portfolio level, balancing priorities, risk, and resources while maintaining asset0level rigor and accountability.
• Credibility and effectiveness representing Clinical Development at senior governance forums, with strong executive presence and influence.
• Advanced cross0functional and matrix leadership skills, with a natural connector mindset across research, development, medical, commercial, and precision medicine partners.
• Openness to and fluency with innovative development approaches (e.g., AI/ML, novel trial designs, external and real0world data) where they add value.
• Commitment to fostering a culture of scientific excellence, empowerment, inclusion, and continuous improvement in a complex global environment.

PLEASE NOTE: This career opportunity offers hybrid working and requires an on-site office presence (minimum of two days a week) at one of GSK0s UK (Stevenage or London HQ); US(Collegeville, PA or Waltham, MA) sites; or Switzerland (Zug).

Basic Qualifications:

• Medical degree (MD, MBBS, MBChB or international equivalent) is required.
• Board certification/eligibility or registration in a primary or medical specialty.
• Oncology drug development experience in the pharmaceutical industry.
• Leadership experience of early- and focused late-phase oncology development programs from first-in-human through registrational studies and launch readiness.
• Experience leading Antibody Drug Conjugate or other targeted oncology development programs.
• Experience holding accountability for asset-level or portfolio-level clinical development strategy, governance, and execution.
• Experience interacting with global health authorities and supporting regulatory submissions and approvals.
• Experience leading global cross-functional teams in complex matrix environments.

Preferred Qualifications:

• Board certification/eligibility or registration in medical oncology, hematology/oncology
• Strong experience in governance leadership, scientific narrative ownership, portfolio influence, and executive-level decision-making.
• Experience in translational research, including the application of translational science to inform clinical development strategies and decision-making.
• Experience utilizing innovative development approaches, including advanced analytics, AI/ML, real-world evidence, or novel trial design

Skills

Clinical Data Interpretation, Clinical Trial Designs, Clinical Trials Monitoring, Digital Fluency, Drug Development, Drug Regulatory Affairs, Evidence Based Decision Making, Executive Presence, Hematology and Oncology, Learning Agility, Matrix Leadership, Real World Evidence (RWE), Scientific Presentations, Strategic Direction

 If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $242,250 to $403,750. The US salary ranges take into account a number of factors including work location within the US market, the candidate0s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave. If salary ranges are not displayed in the job posting for a specific country, the relevant compensation will be discussed during the recruitment process.

Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.